Clinical Trial Update: Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea

View source ↗

Summary

This clinical trial update notes that the HER2 Advanced Gastric Epidemiology study in Korea has completed. The sponsor is Hoffmann-La Roche and the study focuse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer | Status: COMPLETED